Related Announcements

PAR-21-313 - Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

This Notice announces the participation of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), effective for the February 16, 2022 due date, in Funding Opportunity Announcement (FOA) PAR-21-313, "Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)"

The following sections of PAR-21-313 have been modified (changes shown in bold italics) to reflect the participation of NIBIB in this FOA.

Part 1. Overview Information
Components of Participating Organizations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Human Genome Research Institute (NHGRI)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Assistance Listing Number(s)

93.847, 93.172, 93.286

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical, clinical, behavioral and social sciences research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Human Genome Research Institute (NHGRI) or the National Institute of Biomedical Imaging and Bioengineering (NIBIB).

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Purpose and Need for the Program

This FOA is intended to provide support for new investigators from diverse backgrounds, including those from groups that are nationally underrepresented in the biomedical sciences, who are interested in conducting research projects within the scientific mission areas of the NIDDK, the NHGRI or the NIBIB. 

This program will enable new investigators to gain additional research experience and obtain preliminary data on which to base a subsequent research grant application (i.e., R01 or equivalent) within the scientific mission areas of the NIDDK, the NHGRI or the NIBIB.

Specific Areas of Research Interest

NIBIB: NIBIB interests include the development and integration of advanced bioengineering, sensing, imaging, and computational technologies for the improvement of human health and medical care. An application is not within the NIBIB mission if its principal focus is the development of a technology with the goal of understanding basic biological function or pathological mechanisms. Additionally, NIBIB only supports projects developing platform technologies that are applicable to a broad spectrum of disorders and diseases. However, applicants may propose research that utilizes only a single tissue, organ, or physiological condition as a model system to facilitate the development of what is expected to be a more broadly applicable enabling technology. Potential applicants are encouraged to contact the NIBIB Scientific/Research Contact in Section VII. Agency Contacts to determine if their research fits within the NIBIB mission.

NIBIB funding of clinical trials will be in accordance with NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications." Briefly, NIBIB will only support mission-focused (see NIBIB's program areas) early-stage clinical trial applications, i.e., feasibility, Phase I, first-in-human, safety, or other small clinical trials, that inform early stage technology development. NIBIB will not support applications proposing pivotal, Phase II, III, IV, or trials in which the primary outcome is efficacy, effectiveness, or a post-market concern. Also, mechanistic trials are not supported unless the primary focus of the project is on technology development.

This FOA will only support research within the mission of the NIDDK, the NHGRI or the NIBIB.

Programmatic Approach

To minimize the loss of competitive investigators from diverse backgrounds, and to promote successful transitions to established investigator levels, it is imperative to provide funding opportunities to support investigators actively conducting research studies but without substantial preliminary data for them to be fully competitive at the R01 levels in all areas of interest to the NIDDK, the NHGRI or the NIBIB.

Section VII. Agency Contacts

Scientific/Research Contact(s)

Zeynep Erim, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: (301) 451-4797
Email: [email protected] 

Financial/Grants Management Contact(s)

Monique Binger, Ph.D.
National Institute of Biomedical Engineering and Bioengineering (NIBIB)
Telephone: 301-451-4787
Email: [email protected]

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Zeynep Erim, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: (301) 451-4797
Email: [email protected]